LUND, Sweden--(BUSINESS WIRE)--Cantargia AB (STO:CANTA) Interim Report for the third quarter 2015 is now available on the company web-site (www.cantargia.com). An extract from the report is presented below.
Significant events in the third quarter of 2015
In the beginning of July Cantargia announced that the Company had signed an agreement with Glycotope Biotechnology GmbH for production of its CAN04 drug candidate.
Help employers find you! Check out all the jobs and post your resume.
